218772 Caspase Inhibitor Set II - Calbiochem

Caspase Inhibitor Set II - Calbiochem MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.
Primary Target: caspase-1, caspase-2, caspase-4, caspase-5, caspase-6, caspase-7, caspase-8, caspase-9
218772
  
Retrieving price...
Price could not be retrieved
Minimum Quantity needs to be mulitiple of
Upon Order Completion More Information
You Saved ()
 
—
Request Pricing
—
Limited AvailabilityLimited Availability
In Stock 
Discontinued
Limited Quantities Available
Availability to be confirmed
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

       

      Contact Customer Service

      Overview

      Replacement Information

      Key Spec Table
      Description
      Overview

      This product has been discontinued.



      A set of eight cell-permeable, irreversible inhibitors of various caspase-family proteases. Contains 250 µg each of Caspase-1 Inhibitor VI, Z-YVAD-FMK (Cat. No. 218746); Caspase-2 Inhibitor I, Z-VDVAD-FMK (Cat. No. 218744); Caspase-3 Inhibitor II, Z-DEVD-FMK (Cat. No. 264155); Caspase-5 Inhibitor I, Z-WEHD-FMK (Cat. No. 218753); Caspase-6 Inhibitor I, Z-VEID-FMK (Cat. No. 218757); Caspase-8 Inhibitor II, Z-IETD-FMK (Cat. No. 218759); Caspase-9 Inhibitor I, Z-LEHD-FMK (Cat. No. 218761); and Caspase Inhibitor III, Boc-D-FMK (Cat. No. 218745). Supplied with a data sheet.
      Catalogue Number218772
      Brand Family Calbiochem®
      References
      ReferencesThornberry, N.A., and Lazebnik, Y. 1998. Science 281, 1312.
      Humke, E.W., et al. 1998. J. Biol. Chem. 273, 15702.
      Takahashi, A., et al. 1997. Exp. Cell Res. 231, 123.
      Thornberry, N.A., et al. 1997. J. Biol. Chem. 272, 17907.
      Nicholson, D.W., et al. 1995. Nature 376, 37.
      Thornberry, N.A., et al. 1992. Nature 356, 768.
      Product Information
      FormSolid
      ReversibleN
      Quality LevelMQ100
      Applications
      Biological Information
      Primary Targetcaspase-1, caspase-2, caspase-4, caspase-5, caspase-6, caspase-7, caspase-8, caspase-9
      Secondary targetgranzyme B
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage -20°C
      Protect from Moisture Protect from moisture
      Do not freeze Ok to freeze
      Special InstructionsFrom Catalog:
      Desc. Field- added "A set of eight cell-permeable, irreversible inhibitors of various caspase-family proteases
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications

      Documentation

      Caspase Inhibitor Set II - Calbiochem SDS

      Title

      Safety Data Sheet (SDS) 

      Caspase Inhibitor Set II - Calbiochem Certificates of Analysis

      TitleLot Number
      218772

      References

      Reference overview
      Thornberry, N.A., and Lazebnik, Y. 1998. Science 281, 1312.
      Humke, E.W., et al. 1998. J. Biol. Chem. 273, 15702.
      Takahashi, A., et al. 1997. Exp. Cell Res. 231, 123.
      Thornberry, N.A., et al. 1997. J. Biol. Chem. 272, 17907.
      Nicholson, D.W., et al. 1995. Nature 376, 37.
      Thornberry, N.A., et al. 1992. Nature 356, 768.

      Brochure

      Title
      Caspases and other Apoptosis Related Tools Brochure
      Data Sheet

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision04-June-2008 RFH
      DescriptionApoptosis is a normal process in development and morphogenesis. Many cells can be activated to undergo apoptosis following the interaction of selected ligands with cell surface receptors. Receptor-mediated apoptosis involves the activation of caspases (cysteine-containing aspartate-specific proteases). A distinctive feature of caspases is the requirement of an aspartic acid residue in the substrate P1 position.

      Caspase inhibitors act by binding to the active site of caspases and form either a reversible or an irreversible linkage. Caspase inhibitor design includes a peptide recognition sequence attached to a functional group such as an aldehyde (CHO), chloromethylketone (CMK), fluoromethylketone (FMK), or fluoroacyloxymethylketone (FAOM). Caspase inhibitors with a CHO group are reversible and those with a CMK, FMK, or FAOM group are irreversible. FMK exhibits slightly less reactivity than CMK and therefore is more specific for the enzyme being inhibited.
      FormSolid
      Storage -20°C
      Protect from moisture
      Do Not Freeze Ok to freeze
      Special InstructionsFrom Catalog:
      Desc. Field- added "A set of eight cell-permeable, irreversible inhibitors of various caspase-family proteases
      Toxicity Standard Handling
      ReferencesThornberry, N.A., and Lazebnik, Y. 1998. Science 281, 1312.
      Humke, E.W., et al. 1998. J. Biol. Chem. 273, 15702.
      Takahashi, A., et al. 1997. Exp. Cell Res. 231, 123.
      Thornberry, N.A., et al. 1997. J. Biol. Chem. 272, 17907.
      Nicholson, D.W., et al. 1995. Nature 376, 37.
      Thornberry, N.A., et al. 1992. Nature 356, 768.